The short version of melanotan-2 fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-07 and is reviewed periodically as new material appears.
The material is commonly handled as a lyophilized powder in sealed vials. The solid dissolves readily in water and in polar organic solvents, producing a clear solution after reconstitution. Light, heat and repeated freeze-thaw cycles are the concerns most often raised in handling guidance, because peptide bonds and the constrained ring can degrade. Working solutions are generally prepared fresh, and material left in solution is treated as less stable than the dry form. These properties shape how laboratories store and aliquot reference material.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Retention time supports identity, while the mass spectrum confirms the molecular weight of the intact peptide. Purity is frequently reported as a percentage of total peak area, a figure that depends on the wavelength, column and gradient used. Impurity profiling may also look for truncated sequences, oxidised forms and residual counterions. Amino acid analysis and peptide mapping provide orthogonal confirmation when required.
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
Melanocytes are the pigment-producing cells of the skin, and they carry melanocortin-1 receptors on their surface. When the receptor is activated, cyclic adenosine monophosphate rises inside the cell and raises the activity of enzymes such as tyrosinase, which increases melanin output. Melanotan-2 binds melanocortin-1 receptors in vitro and in animal models, and this binding is generally described as the basis for the tanning effect. Other receptors account for different effects: melanocortin-4 receptors contribute to appetite and erectile signalling, while melanocortin-3 and melanocortin-5 receptors contribute to energy balance and exocrine function.
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typically supplied as a lyophilized solid in a sealed vial |
| Solubility class | Soluble in water and polar organic solvents | Reconstituted solutions are generally clear |
| Typical storage temperature | -20 degrees Celsius or below, dry | Protect from light; avoid repeated freeze-thaw cycles |
| Common analytical methods | Reversed-phase HPLC-UV, LC-MS | Used for purity estimation and mass confirmation |
| Reported purity range | Area percentage above 95 percent | Reporting practice and acceptance limits differ by laboratory |
Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.
Solid peptide kept dry at minus twenty degrees Celsius, shielded from light and moisture, is generally considered stable for extended periods. Solutions are divided into single-use aliquots and held at minus twenty or minus eighty degrees Celsius, because repeated freeze-thaw cycles promote aggregation and loss of material to container surfaces. Hydrolysis of the backbone and oxidation of tryptophan are the principal degradation routes in aqueous solution, and both accelerate at ambient temperature. Hygroscopic uptake after a vial is opened can also shift the actual mass weighed, which affects any concentration calculated from it.
Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Lyophilised peptide powder is comparatively stable when kept dry, cold and protected from light. Once dissolved, the molecule is exposed to hydrolysis, oxidation and microbial growth, and degradation accelerates at higher temperatures and in alkaline solution. Repeated freeze-thaw cycles concentrate solutes and promote aggregation. Handling guidance for research peptides commonly clusters around freezer temperatures for powder and short refrigerated use for reconstituted solutions, with pH control and sterile technique applied throughout.
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
It is marketed as a combination drug with mecobalamin under the brand names Agemax-P, Alphamix-PG, Freenerve-P, Gaben, Macraberin-P, Mecoblend-P, Mecozen-PG, Meex-PG, Methylnuron-P, Nervolin, Nervopreg, Neurica-M, Neuroprime-PG, Neutron-OD, Nuroday-P, Nurodon-PG, Nuwin-P, Pecomin-PG, Prebel-M, Predic-GM, Pregacent-M, Pregamet, Preganerv-M, Pregeb-M OD, Pregmic, Prejunate Plus, Preneurolin Plus, Pretek-GM, Rejusite, Renerve-P, Safyvit-PR, Vitcobin-P, and Voltanerv with Methylcobalamin and ALA by Cogentrix Pharma. In the US, Lyrica is marketed by Viatris after Upjohn was spun off from Pfizer.
==== United States ==== In March 2020, United States President Donald Trump announced that remdesivir was available for "compassionate use" for people with COVID‑19; FDA Commissioner Stephen Hahn confirmed the statement at the same press conference. It was later revealed that Gilead had been providing remdesivir in response to compassionate use requests since 25 January. On 23 March 2020, Gilead suspended access for compassionate use (excepting cases of critically ill children and pregnant women), due to short supply, citing the need to continue to provide it for testing in clinical trials. In May 2020, the US Food and Drug Administration granted Gilead emergency use authorization (EUA) for remdesivir to be distributed and used by licensed healthcare providers to treat adults and children hospitalized with severe COVID‑19. Severe COVID‑19 is defined as patients with an oxygen saturation (SpO2) <= 94% on room air or requiring supplemental oxygen or requiring mechanical ventilation or requiring extracorporeal membrane oxygenation (ECMO), a heart–lung bypass machine. Distribution of remdesivir under the EUA was controlled by the US government for use consistent with the terms and conditions of the EUA. Gilead supplied remdesivir to authorized distributors, or directly to a US government agency, who distributed it to hospitals and other healthcare facilities as directed by the US government, in collaboration with state and local government authorities, as needed.
=== Excitotoxicity in Stroke and Neurodegeneration === Excessive activation of AMPARs, particularly those lacking the GluA2 subunit, leads to increased calcium permeability, contributing to neuronal injury and death—a phenomenon known as excitotoxity. This mechanism in involved in acute events such as stroke and in chronic neurodegenerative diseases. For instance, in ALS, motor neurons exhibit elevated levels of calcium-permeable AMPARs, rendering them more susceptible to excitotoxic damage.
Within days of the Alvor Agreement, the Central Intelligence Agency launched its own programme, Operation IA Feature, to arm the FNLA, with the stated objective of "prevent[ing] an easy victory by Soviet-backed forces in Angola". The United States was searching for regional allies to take part in Operation IA Feature and perceived South Africa as the "ideal solution" in defeating the pro-Soviet MPLA. With tacit American encouragement, the FNLA and UNITA began massing large numbers of troops in northern and southern Angola, respectively, in an attempt to gain tactical superiority. The transitional government installed by the Alvor Agreement disintegrated and the MPLA requested support from its communist allies. Between February and April 1975, the MPLA's armed wing, the People's Armed Forces of Liberation of Angola (FAPLA), received shipments of Soviet arms, mostly channelled through Cuba or the People's Republic of the Congo. At the end of May, FAPLA personnel were being instructed in their use by a contingent of about 200 Cuban military advisers. Over the next two months, they proceeded to inflict a series of crippling defeats on the FNLA and UNITA, which were driven out of the Angolan capital, Luanda.
Sources: en.wikipedia.org
==== Sanctions ==== On 15 September, the company issued a public apology for the contaminated powdered milk; Sanlu was ordered to halt production, and to destroy all unsold and recalled products. Authorities reportedly seized 2,176 tons of powdered milk in Sanlu's warehouses. An estimated 9,000 tons of product had been recalled. Tian Wenhua, chairwoman and general manager of Sanlu and Secretary of the Sanlu Communist Party chapter was stripped of her party and functional posts during an extraordinary meeting of the Hebei provincial standing committee of the CCP; four Shijiazhuang officials, including vice mayor in charge of food and agriculture, Zhang Fawang, were reportedly removed from office. Shijiazhuang Mayor Ji Chuntang resigned on 17 September. Li Changjiang, minister in charge of the AQSIQ, was forced to resign on 22 September after the State Council inquest concluded he was responsible for the "negligence in supervision". Investigators also blamed the Shijiazhuang government. Local Party Secretary Wu Xianguo was fired on the same day.
In August 2008, Helton was diagnosed with a degenerative back condition, putting his health and ability to continue play in question. On May 19, 2009, Helton got his 2,000th hit, a single, during an 8–1 road loss to the Atlanta Braves. On July 22, Helton hit his 500th career double in a 4–3 home victory over the Arizona Diamondbacks. He became the 50th player in MLB history to hit 500 career doubles and the fastest to do since 1954. Helton also joined Babe Ruth, Stan Musial, Lou Gehrig and Ted Williams as the only players in MLB history to have at least 500 doubles, 320 home runs and a .325 batting average for a career. On March 11, 2010, Helton signed a two-year, $9.9 million contract extension, which ran through the 2013 season. Helton's degenerative back condition sent him back to the disabled list in July. He returned from the DL in August and hit .256 with 8 home runs and 37 RBI for the season. After the season, Helton said he would return to the Rockies in 2011, dispelling rumors of a possible retirement. On February 15, 2011, Helton announced his intention to play baseball for three more years, preferably for the Rockies. On June 30 he played his 2,000th career game. In 2012, Helton continued to deal with what was by now a chronic health issue. On April 14, he drove a 2-run walk-off home run through heavy rain, the seventh walk-off of his career. On July 13, Helton was placed on the 15-day disabled list due to inflammation in his right hip. He had played 63 games to that point, and was batting .235.
As the Kulturkampf declined, debates about the character of the party emerged culminating in the Centre dispute, in 1906, after Julius Bachem had published the article "We must get out of the tower!" He called upon Catholic politicians to fulfill Windthorst's word and get out of their perpetual minority position by an effort to increase Protestant numbers among their representatives in parliament. His proposal was met with passionate opposition by the greater part of Catholic public, especially since it also included the Christian trade unions and other Catholic organisations. No side could win the upper hand, when the outbreak of World War I ended the dispute. After the war, there were many proposals on how the reform the party. Heinrich Brauns published the Cologne Program (Kölner Programm), which proposed the re-formation of the Zentrum under a new name (Christliche Volkspartei, CVP). This proposal was rejected, with only a few regions adopting it for the 1919 election; the party instead adopted the Berlin Guidelines (Berliner Leitsätze), which were more moderate but failed at making the Zentrum attractive for Protestant voters too. Adam Stegerwald, leader of the Christian trade unions, made another attempt at transcending the party's exclusively Catholic character and uniting Germany's fragmented party spectrum. In 1920 he advocated the formation of a broad Christian middle-party, that would transcend denominations and social classes and which could push back the Social Democrats' influence.
Sources: en.wikipedia.org
Arthur J. Ammann (August 12, 1936 – August 15, 2021) was an American pediatric immunologist and advocate known for his research on HIV transmission, discovering in utero transmission and the risk of contaminated transfusions and blood products, and his role in the development of the first successful vaccine to prevent pneumococcal infection in 1977. He founded Global Strategies for HIV Prevention and was Clinical Professor of Pediatrics at the UCSF Medical Center.
Corticosteroids have become some of the most commonly incorporated lightening agents. Long-term usage over large areas of skin may promote percutaneous absorption, which can produce complications such as skin atrophy and fragility, glaucoma, cataracts, edemas, osteoporosis, menstrual irregularities, and growth suppression. A 2000 study performed in Dakar, Senegal, indicated that chronic usage of skin lighteners was a risk factor for hypertension and diabetes. Chemically lightened skin is more highly susceptible to sun damage and dermal infection. Long-term users of skin bleachers can easily develop fungal infections and viral warts. Pregnant users may also experience health complications for both them and their children.
Within a few months of his joining the Committee, what had previously been an innovative and forward-looking group became riven with strife. It was strictly Lindemann versus the rest, with his hostility to radar and his insistence on totally impractical ideas about intercepting enemy aircraft by means of wires dangled from balloons, or by infrared, which at that time simply did not have the sensitivity to detect aircraft at long range. Churchill's backing meant the other members' complaints about his behaviour were ignored. The matter was eventually referred back to Lord Swinton, the new Secretary of State for Air. Swinton solved the problem by dissolving the original Committee and reforming it with Appleton in Lindemann's place. As the development effort grew, Watt requested a central research station be established "of large size and with ground space for a considerable number of mast and aerial systems". Several members of the team went on scouting trips with Watt to the north of Orfordness but found nothing suitable. Then Wilkins recalled having come across an interesting site about 10 mi (16 km) south of Orfordness, some time earlier while on a Sunday drive. He recalled it because it was some 70–80 ft (21–24 m) above sea level, which was unusual in that area. The large manor house on the property would have ample room for experimental labs and offices. In February and March 1936, the team moved to Bawdsey Manor and established the Air Ministry Experimental Station (AMES). When the scientific team left in 1939, the site became the operational CH site RAF Bawdsey.
=== Irish === Ancient Order of Hibernians Knights of Equity St. Patrick's Alliance of America - Founded in 1868 by members of the Friendly Sons of St. Patrick and other groups, mostly Irish Catholic. However, the Alliance's ritual emphasized freedom of religion and denounced bigotry from any source. Other elements were borrowed from the Foresters and other like groups. The Alliance's emblem was a disc showing the tree of life and the letters S. P. A. of A. The Alliance provided sick and death benefits and benefits for the loss of a wife. Membership was open to all regardless of political or religious belief as long as one was of Irish descent. There were a reported 50,000 members concentrated in "New England, Middle, Pacific Coast, and some other States". The National Secretary was based in Newark, New Jersey
Sources: en.wikipedia.org
The dry powder is more stable during transport and storage than a solution. It also allows a known amount of material to be reconstituted at a chosen concentration.
Most certificates state a percentage derived from chromatographic peak area, alongside a mass confirmation. The exact criteria and acceptance thresholds vary between laboratories.
Dry powder is kept frozen or refrigerated and protected from light and moisture. Solutions are handled cold and used promptly to limit degradation.
No. It is a laboratory-made peptide, while the natural hormone is alpha-melanocyte-stimulating hormone, a longer peptide produced by the pituitary gland and by skin cells. Melanotan-2 mimics only a short active region of that hormone and contains non-natural residues such as D-phenylalanine.